4093-17-8

Basic information

• Product Name: Benzoyl chloride, 2,3,6-trichloro-
• CAS NO: 4093-17-8
• Molecular Formula: C7H2Cl4O
• Molecular Weight: 243.904
• Mol File: 4093-17-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: Benzoyl chloride, 2,3,6-trichloro-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoyl chloride, 2,3,6-trichloro-(4093-17-8)
• EPA Substance Registry System: Benzoyl chloride, 2,3,6-trichloro-(4093-17-8)

Safety Data

• Hazardous Substances Data: 4093-17-8(Hazardous Substances Data)

Upstream product

• 50-31-7 2,3,6-TBA 

Downstream Products

• 90325-20-5 2,3,6-trichloro-thiobenzoic acid 
• 25194-91-6 1-(2,3,6-trichlorobenzoyloxy)-1-phenyl-3-methylurea 
• 53083-14-0 2,3,6-Trichloro-benzoic acid 3-oxo-2-(2,4,6-trimethyl-phenyl)-3H-inden-1-yl ester 
• 38431-30-0 2,3,6-Trichloro-thiobenzoic acid S-(2-chloro-3-dipropylcarbamoylsulfanyl-propyl) ester 
• 53083-64-0 2,3,6-Trichloro-benzoic acid 2-(2,6-dichloro-phenyl)-3-oxo-3H-inden-1-yl ester 
• 38332-06-8 2,3,6-Trichloro-N-{[(E)-2,6-dimethyl-phenylimino]-methyl}-N-methyl-benzamide 
• 28359-60-6 2,3,6-Trichloro-benzoic acid (5-chloro-2-dimethylamino-phenyl)-o-tolyl-methyl ester 
• 38145-49-2 2,3,6-Trichloro-N-methyl-N-[(E)-phenyliminomethyl]-benzamide 
• 25194-90-5 1-(2,3,6-trichlorobenzoyloxy)-1-(3-chlorophenyl)-3-methylurea 
• 25259-24-9 1-(2,3,6-trichlorobenzoyloxy-1-(3,4-dichlorophenyl)-3-methylurea 
• 128998-11-8 2,3,6-Trichloro-benzoic acid 6-hydroxymethyl-4-oxo-4H-pyran-3-yl ester 
• 100526-61-2 bis-(2,3,6-trichloro-benzoyl)-disulfane 

Relevant articles and documents

PYRAZOLE DERIVATIVES FOR THE INHIBITION OF CDK' S AND GSK' S

The invention provides compounds of the formula (I), or salts, tautomers, N-oxides or solvates thereof wherein: R1 is selected from: (a) 2,6-dichlorophenyl; (b) 2,6-difluorophenyl; (c) a 2,3,6-trisubstituted phenyl group wherein the substituents for the phenyl group are selected from fluorine, chlorine, methyl and methoxy; (d) a group R0; (e) a group R a; (f) a group Rlb; (g) a group Rlc; (h) a group Rld; and 0) 2,6-difluorophenylamino ; wherein R )0υ, r R> llaa, T Rj I1bD, T R) I1cC, r R> Iidα, r R?2zaa, r R>22bD and RJ are as defined in the claims. The compounds have activity as inhibitors of cdk kinase (such as cdkl or cdk2) and glycogen synthase kinase-3 activity.